According to Sudarshan Sukhani of s2analytics.com, one may avoid Jaiprakash Associates and Ranbaxy Laboratories.
first published: Feb 10, 2014 02:28 pm
A collection of the most-viewed Moneycontrol videos.

Nifty recovers from day’s low to edge back above 26,000 | Closing Bell Live

Tax Saving Tips: How sections 54 & 54F can reduce tax to zero

Can Nifty Extend Its Upmove After Back-To Back Gains? Insurance Stocks In Focus| Opening Bell Live

From Mini-Mumbai to the Real Mumbai: What Brought This Tenant to Andheri | The Tenant
You are already a Moneycontrol Pro user.


